Pharmafile Logo
Pharmafocus logo
Advanced Search

US

Showing 15 posts of 324 posts found.

Novartis sheds generics plant and 450 jobs amid pricing pressure

October 18, 2017
Manufacturing and Production, Research and Development Novartis, US, closure, generics, manufacturing, pharma

Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …

News
shutterstock_254160583

Lupin scoops up women’s health specialist Symbiomix for $150 million

October 11, 2017
Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma

The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …

News
novo_flag

Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million

September 6, 2017
Research and Development, Sales and Marketing FDA, Novo Nordisk, US, US Justice Department, Victoza, diabetes, pharma, pharmaceutical

Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …

News

Sanofi backs out of controversial Zika vaccine project

September 4, 2017
Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …

News
bribe

One in twelve US doctors accepted opioid-related payments from pharma, finds study

August 10, 2017
Medical Communications, Sales and Marketing US, bribe, drugs, life sciences, medicine, opioids, pharma, pharmaceutical

In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …

News
gilead-sciences

FDA gives approval for Gilead’s hepatitis C therapy

July 19, 2017
Research and Development, Sales and Marketing FDA, Gilead, US, Vosevi, biotech, drugs, healthcare, pharma, pharmaceutical

The FDA has announced that it has chosen to approve Vosevi (sofosbuvir/velpatasvir/voxilaprevir), Gilead’s investigational drug for the treatment of chronic …

News
brenda-fitzgerald-2

New director of CDC courts controversy from all angles

July 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, Trump, US

It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …

Appointment
shutterstock_254160583

Sanofi to pay $20m fine for overcharging US veterans

April 4, 2017
Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US

Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …

News
eu_and_fda

EU-US reach landmark deal on mutual recognition of manufacturing inspection

March 3, 2017
Medical Communications EMA, EU, FDA, US

The European Union and the US has announced that an agreement has been made to mutually recognise inspection of drug …

News
barack-obama-1174489_960_720

Obama seals $6.3 billion 21st Century Cures Act

December 14, 2016
Medical Communications, Research and Development Biden, Obama, US, congress

President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …

News
pfizer_brussels

Pfizer sues Texas agency over leak of drug prices

November 21, 2016
Medical Communications, Sales and Marketing Drug pricing, Pfizer, US, texas

Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …

News

Myelofibrosis market to increase to be worth over $1 billion by 2025

November 16, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, US, myelofibrosis

The myelofibrosis market is expected to grow from $545.2 million in 2015 to $1.02 billion by 2025, almost doubling in …

News
cuba_us_flags

FDA approves clinical trial of Cuban lung cancer vaccine

November 1, 2016
Manufacturing and Production, Sales and Marketing Cuba, US, Vaccine, cimavax, clinical trials

The thawing of relations between the US and Cuba has allowed a pioneering treatment for non-small cell lung cancer to …

News
lilly_scientists

Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …

News
sunpharma

Sun Pharmaceuticals hit with recall of over 31 thousand bottles of anti-depressants

October 13, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, India, US, america, sun pharmaceutical

Sun Pharmaceuticals have been forced to recall 31,762 bottles of anti-depressants from the US market after the FDA issued a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025